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Abstract 
 
Congenitally corrected transposition of the great arteries (CCTGA) is a rare 
congenital heart disease that commonly results in congestive heart failure due to 
exposure of the anatomic right ventricle to systemic pressures. Additional 
anatomic abnormalities, such as situs inversus, in which the viscera are mirror 
images of normal anatomy, or dextrocardia in which the heart apex is located on 
the patient’s right, once were contraindications to transplant in the treatment of 
advanced heart failure. However, recent advancements now allow for the 
management of heart failure through mechanical circulatory support and 
subsequent transplant. This case presents a 52 year-old man with advanced 
heart failure secondary to CCTGA and dextrocardia situs inversalis totalis that 
was managed with a ventricular assist device (VAD) after maximal medical   
treatment, and subsequently received an orthotopic heart transplant. This case 
will also review CCTGA in relation to heart failure and the surgical challenges 
faced in terms of ventricular assist device implantation and orthotopic heart 
transplant.  
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Introduction 
 
Congenitally corrected transposition of the great arteries (CCTGA), or Levo-
Transposition of the Great Arteries (L-TGA) is a rare form of congenital heart 
disease that results from abnormal leftward looping of the primitive heart tube 
yielding reversal of the ventricles. Patients with this condition exhibit both 
atrioventricular and ventriculoarterial discordance.  As an isolated condition, 
patients are asymptomatic during early life.  Nearly 90% of cases are associated 
with additional cardiac abnormalities, which may account for any early symptoms 
observed.1 The most common of these conditions are ventricular septal defects, 
pulmonary outflow obstructions, as well as tricuspid and mitral valve 
abnormalities. 
 
Dextrocardia can be an isolated occurrence, but is commonly associated with 
situs inversus totalis.2  Typically, this condition is asymptomatic, although it may 
be associated with occurrence of congenital conditions such as Kartagener’s 
Syndrome (Primary Ciliary Dyskinesia), congenital transposition of the great 
arteries, and various other conditions, all in varying combinations.3  In the case of 
NYHA stage IV Heart Failure in these patients, situs inversus totalis was once 
considered a contraindication to mechanical circulatory support and heart 
transplantation..  However, recent advancements have made it possible to 
overcome this limitation.4  Special considerations may include anastomosis of 
donor and recipient IVC and creation of a conduit out of the recipient’s right 
atrium.2-7  Prior to heart transplantion in this patient population, correction of 
extracardiac congenital conditions may be required.8  
 
Many patients with CCTGA and situs inversus develop congestive heart failure 
(CHF) later in life. In these patients, mechanical circulatory support is one option, 
which presents increased technical difficulty with respect to surgical intervention. 
 Southard et al have described one such case of ventricular assist device (VAD) 
placement in a patient with both dextrocardia and CCTGA.9   Other cases have 
been reported in the literature regarding VAD placement or transplantation in 
either of these two conditions.8,10,11  We present a case of systemic VAD 
placement in a patient with CCTGA and dextrocardia situs inversus to address 
the challenges of heart failure management in this particular patient population.  
 
Clinical Summary 
 
A 52 year-old man with a known history of CCTGA and dextrocardia situs 
inversus totalis presented in January 2013 with worsening shortness of breath, 
dyspnea on exertion, and lower extremity edema.  Ejection fraction was 15%. His 
past medical history was significant for chronic atrial flutter, deep vein and atrial 
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thromboses, chronic kidney disease, and pulmonary hypertension.  Outpatient 
medical management consisted of a beta blocker, angiotensin receptor blocker, 
loop diuretic, digoxin, and sildenafil. 
 
He was in atrial fibrillation on admission.   After optimization of hemodynamics 
with milrinone 0.5 mcg/kg/min and diuresis, catheterization demonstrated right 
atrial pressure 7mmHg, pulmonary artery pressure 48/26 with a mean of 
34mmHg and pulmonary capillary wedge pressure 9mmHg.  Cardiac index 
remained reduced at1.89 L/min/m2 by thermodilution and 1.78 L/min/m2 by 
Fick’s method.  Pulmonary vascular resistance was 6.6 Wood units.   Coronary 
arteries were normal.  It was determined that pulmonary ventricular function 
(morphological LV) was sufficient to allow use of a systemic ventricular assist 
device.   
 
Transesophageal echocardiography (TEE) demonstrated biventricular systolic 
failure with an ejection fraction (EF) of 15%, severe regurgitation of the systemic 
atrioventricular valve (morphologic tricuspid valve) with a markedly dilated 
systemic atrium.  A small membranous VSD with continuous flow was noted. 
Flow was not measured.  
 
Despite optimal medical management, the patient was admitted with rapidly 
deteriorating NYHA Class IV, Stage D heart failure and was subsequently 
evaluated by an interdisciplinary team for the placement of a VAD.  A cardiac 
MRI (Fig. 1) confirmed atrial and visceral situs inversus with L-transposition, 
biventricular hypokinesis with severe dilation of the systemic ventricle (systemic 
ejection fraction 23%), systemic atrio-ventricular valvular insufficiency, and 
pulmonary artery dilation to 5.7cm. The anatomy of the pulmonary veins and 
systemic thoracic veins was conventional.  Based on hemodynamic and 
anatomic data, he was referred for mechanical circulatory support.  
 
Implantation of the HeartWare HVAD ventricular assist device was performed 
through a median sternotomy.  The patient’s anatomy was identified carefully, 
with the superior vena cava (SVC) and inferior vena cava (IVC) clearly on the left 
side, and the systemic ventricle was obviously a morphologic right ventricle.  The 
aorta and the pulmonary artery were relatively normally oriented, although the 
pulmonary artery was quite large, consistent with known pulmonary 
hypertension.   An appropriate site on the ventricular free wall towards the right 
side of the left anterior descending coronary artery was identified.  The HVAD 
ring was placed on the lateral side of the apex of the systemic (morphologic right) 
ventricle to approximate the permanent position of the VAD, allowing for stitches 
to be placed through the ventricular wall and the VAD ring.  The outflow graft was 
anatamosed to the ascending aorta.  Upon removal of the ventricular core, a 
papillary muscle had been injured, leading to a flail systemic atrioventricular 
valve leaflet.  This was confirmed by intraoperative TEE, and the valve was 
replaced with a 31 mm pericardial tissue valve by approaching the mitral valve 
through the dome of the left atrium.  The patient was successfully weaned from 
cardiopulmonary bypass with excellent VAD function (Fig 2). 
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 Figure 1. Preoperative MRI revealing dextrocardia and cardiomegaly (A),   
 marked dilation of the pulmonary trunk (B), and situs inversus totalis (C). 
 
 
 
Figure 2. Postoperative chest x-ray showing right-sided placement of VAD 
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While recovering in the ICU, the patient was weaned from pressors and placed 
on sildenafil.  Post op day 1, the patient developed complete atrioventricular 
block and a dual-chamber implantable cardioverter-defibrillator was implanted on 
post-operative day 2.  The patient was extubated on post-operative day 9.   
Catheterization on post-operative day 22 showed excellent flow and filling 
pressures, with improved cardiac index (2.53 L/min/m2 by thermodilution, and 
3.51 by Fick’s method) and improvement of pulmonary hypertension (3.3 Wood 
units by thermodilution, 2.1 Wood units by Fick’s method).  Post-operative 
complications included a transient ischemic attack of right sided weakness that 
resolved right before discharge on post-operative day 28.  The patient was found 
to have aspirin resistance via thromboelastogram, and he was placed on 
clopidogrel 75mg. 
  
With the exception of difficulties related to anticoagulation that resulted in a 
subarachnoid hemorrhage without residual deficits, the patient was relatively 
stable with outpatient VAD management until a donor heart was located. 
 
In May 2014, 1 year and 5 months after VAD placement, a suitable donor heart 
became available and the patient underwent successful orthotopic heart 
transplantation.  Redo median sternotomy was performed, significant scar tissue 
within the mediastinum was dissected carefully.  The patient was heparinized 
and cannulated.  Cardiopulmonary bypass was initiated, the aorta was cross-
clamped and the heart with its accompanying VAD was fully excised.  The left-
sided SVC was addressed by using a 16mm externally supported Gore-Tex graft, 
directed left to right across the diaphragm.  Once the left atrium was 
anastomosed to the left atrial cuff, the IVC graft was anastomosed to the donor 
IVC.  The recipient pulmonary artery was much larger in diameter than the donor 
pulmonary artery, requiring complex reconstruction with a bovine pericardial 
patch.  To perform the SVC anastomosis, it was clear that the donor innominate 
vein did not have enough length to reach the recipient SVC, so a 10mm graft was 
placed.  The patient was weaned successfully from cardiopulmonary bypass.  
The chest was left open as hemostasis was not adequate for closure and the 
patient was returned to the ICU.  However, over the next two days, the patient 
developed plethora of the face and neck.  The patient was returned to the OR, 
and a 13mm graft was placed between the recipient SVC and the donor SVC, 
and the 10mm graft was revised to connect the recipient innominate vein and the 
ligated donor jugular vein. (Fig. 3, 4).  All grafts were reconstructed without 
interrupting venous return from the upper body. The chest was closed on post-
operative day 5.   
 
The postoperative course involved multiple arrhythmias treated with amiodarone, 
serratia bacteremia, acute kidney injury, thrombocytopenia, prolonged ventilation, 
pleural effusion requiring thoracentesis, and CO2 retention.  As the left ventricle 
is directly under the sternum, echocardiographic assessment is difficult.  Serial 
measurements of left ventricular function have been made with radionucleotide 
ventriculography.  After a prolonged hospitalization and inpatient rehabilitation, 
he had remained well with normal functional capacity.  Left ventricular function 
has remained normal, now 18 months after transplantation. 
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Figure 3. Illustration demonstrating placement of the 10mm (red arrow) 
recipient innominate vein to donor right jugular vein graft and 13mm (blue 
arrow) recipient SVC to donor SVC graft, and the 16mm (yellow arrow) IVC 
graft. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Postoperative computed tomography scan showing the 10mm (red 
arrow) recipient innominate vein to donor right jugular vein graft and 13mm 
(blue arrow) recipient SVC to donor SVC graft (A), and the 16mm (yellow arrow) 
IVC graft (B). 
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Discussion  
 
CCTGA is a rare congenital anomaly occurring less than 0.5% of patients with 
clinically evident congenital heart disease. CCTGA presents as an 
atrioventricular discordance and ventriculoarterial discordance. Among these 
individuals, 67% with severe associated anomalies and 25% of patients with 
minor or no associated lesions will develop heart failure by age 45.1 The double 
discordance in CCTGA results in a physiologic circulation, and unless there are 
symptomatic associated anomalies, patients with CCTGA may remain 
undiagnosed until the 4th or 5th decade, at which time they present often with 
heart failure.  Physiologically, the long term overload of a morphologic RV 
supplying the systemic circulation, in combination with progressive AV valve 
dysfunction and arrhythmia, overcomes any compensatory hypertrophy and 
results in failure of the systemic ventricle.  Subsequently, this can lead to 
pulmonary hypertension, and eventual biventricular failure.  Therefore, the timing 
of referral for operative interventions in these patients is the major predictor of 
outcome in CCTGA.12   For patients presenting with ventricular failure, options for 
intervention may include inotropic support, valve repair, pulmonary banding, 
anatomic repair via the “double switch” procedure, mechanical circulatory 
support, and ultimately cardiac transplantation.  Although these patients are 
already high risk due to anatomical considerations and technical difficulty, 
mechanical circulatory support in patients with CCTGA is a feasible and viable 
option for patients either as a destination therapy or while awaiting 
transplantation.  
 
Until recently, mechanical circulatory support was difficult in these patients, even 
without the concomitant presence of dextrocardia and situs inversus, which is 
evident by the fact that there have been very few cases of placement of a VAD in 
patients with CCTGA in the literature.10,11,13 Additionally, there have been few 
cases of VAD placement in patients with either situs inversus or dextrocardia.  
Based on prior case reports and through our experience with this particular 
patient, it is evident that adjustments have to be made to ensure proper flow 
through the VAD as these devices were designed to reside in the wall of a 
morphologic left ventricle.  In contrast to the near conical shape of the left 
ventricle, the right ventricle is more triangular in shape, with possible inflow 
obstructions such as an additional papillary muscle with accompanying chordae, 
trabeculations, and the moderator band.  Using TEE guidance, these must be 
considered when determining placement of the VAD to prevent inflow 
obstruction.   With the introduction of smaller devices, placement of VADs in this 
particular patient population will become more straightforward.  The HeartWare 
HVAD has a displacement volume of 50 cc. and is intended to be implanted in 
the pericardial space.  The outflow graft has a strain relief design that allows for 
flexible implantation in patients with varied anatomy.   
 
Orthotopic heart transplantation into a space formerly configured to a 
dextrocardic situs inversus heart presents unique challenges.  The main 
challenge is to reconstruct the systemic venous return pathways to 
accommodate a normally configured heart.  This was first described in a case of 
heart-lung transplantation by Miralles et al, in which a large single atrium was 
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created to allow for venous anastomoses.14  This had its own limitations, such as 
acting as point of stasis and possible thrombus formation, apart from its other 
physiological implications.   An alternative, similar to the technique used in our 
case, was described in Deuse et al, consisting of a bi-caval technique with graft 
interposition depending on the length of the donor innominate vein available.4  As 
evidenced by the SVC syndrome requiring graft revision encountered 
postoperatively in our case, special attention must be given to ensure that there 
is adequate venous return. 
 
In conclusion, we report a case of successful HeartWare HVAD placement with 
subsequent orthotopic heart transplantation in a patient with CCTGA and 
dextrocardia situs inversus.  
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